Suspected GHB overdoses in the emergency department
- PMID:15516299
- DOI: 10.1093/jat/28.6.481
Suspected GHB overdoses in the emergency department
Abstract
Blood specimens from 146 suspected gamma-hydroxybutyrate (GHB) overdose cases, presenting to an emergency department in Washington State over a 12-month period, were analyzed for GHB and other drugs. Of these 146 patients, GHB was confirmed in approximately one-third of the patients (N = 54), sometimes in potentially toxic concentrations. These patients were aged between 17 and 59 years (median 28 years), and 83% were male. Blood GHB concentrations ranged from 29 to 490 mg/L (mean 137 mg/L; median 103 mg/L). In 36 (67%) of the 54 patients, other drugs were additionally detected. Ethanol was measured in 22 (41%) patients, with concentrations ranging from 0.01 to 0.26 g/100 mL (median 0.04 g/100 mL). Other commonly co-administered drugs included 3,4-methylenedioxymethamphetamine, marijuana, methamphetamine, cocaine, and citalopram. Frequently observed clinical symptoms on admission for the GHB overdose group included copious vomiting, ataxia, lack of gag reflex, respiratory depression, mild acute respiratory acidosis, unconsciousness, and sudden altered states of consciousness. Many patients required intubation, and several became combative and required restraints. The majority of patients were discharged within 6 h of hospital admission. However, despite presenting with similar clinical symptoms on admission, GHB was not confirmed in 92 of the 146 overdose patients, suggesting that GHB overdose cases may frequently be indistinguishable from other drug overdoses or medical conditions.
Similar articles
- Intoxication by gamma hydroxybutyrate and related analogues: Clinical characteristics and comparison between pure intoxication and that combined with other substances of abuse.Miró Ò, Galicia M, Dargan P, Dines AM, Giraudon I, Heyerdahl F, Hovda KE, Yates C, Wood DM, Liakoni E, Liechti M, Jürgens G, Pedersen CB, O'Connor N, Markey G, Moughty A, Lee C, O'Donohoe P, Sein Anand J, Puiguriguer J, Homar C, Eyer F, Vallersnes OM, Persett PS, Chevillard L, Mégarbane B, Paasma R, Waring WS, Põld K, Rabe C, Kabata PM.Miró Ò, et al.Toxicol Lett. 2017 Aug 5;277:84-91. doi: 10.1016/j.toxlet.2017.05.030. Epub 2017 Jun 1.Toxicol Lett. 2017.PMID:28579487
- Presentations to an urban emergency department in Switzerland due to acute γ-hydroxybutyrate toxicity.Liakoni E, Walther F, Nickel CH, Liechti ME.Liakoni E, et al.Scand J Trauma Resusc Emerg Med. 2016 Aug 31;24(1):107. doi: 10.1186/s13049-016-0299-z.Scand J Trauma Resusc Emerg Med. 2016.PMID:27581664Free PMC article.
- Determination of gamma-hydroxybutyrate (GHB) in biological specimens by gas chromatography--mass spectrometry.Couper FJ, Logan BK.Couper FJ, et al.J Anal Toxicol. 2000 Jan-Feb;24(1):1-7. doi: 10.1093/jat/24.1.1.J Anal Toxicol. 2000.PMID:10654561
- Case series of 226 γ-hydroxybutyrate-associated deaths: lethal toxicity and trauma.Zvosec DL, Smith SW, Porrata T, Strobl AQ, Dyer JE.Zvosec DL, et al.Am J Emerg Med. 2011 Mar;29(3):319-32. doi: 10.1016/j.ajem.2009.11.008. Epub 2010 Apr 28.Am J Emerg Med. 2011.PMID:20825811Review.
- The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.Schep LJ, Knudsen K, Slaughter RJ, Vale JA, Mégarbane B.Schep LJ, et al.Clin Toxicol (Phila). 2012 Jul;50(6):458-70. doi: 10.3109/15563650.2012.702218.Clin Toxicol (Phila). 2012.PMID:22746383Review.
Cited by
- GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.Busardò FP, Jones AW.Busardò FP, et al.Curr Neuropharmacol. 2015 Jan;13(1):47-70. doi: 10.2174/1570159X13666141210215423.Curr Neuropharmacol. 2015.PMID:26074743Free PMC article.Review.
- Gamma-hydroxybutyrate and ethanol effects and interactions in humans.Thai D, Dyer JE, Benowitz NL, Haller CA.Thai D, et al.J Clin Psychopharmacol. 2006 Oct;26(5):524-9. doi: 10.1097/01.jcp.0000237944.57893.28.J Clin Psychopharmacol. 2006.PMID:16974199Free PMC article.Clinical Trial.
- Driving under the influence of gamma-hydroxybutyrate (GHB).Jones AW, Holmgren A, Kugelberg FC.Jones AW, et al.Forensic Sci Med Pathol. 2008;4(4):205-11. doi: 10.1007/s12024-008-9040-1. Epub 2008 May 14.Forensic Sci Med Pathol. 2008.PMID:19291440
- Self-administration of gamma-hydroxybutyric acid (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons.Goodwin AK, Kaminski BJ, Weerts EM.Goodwin AK, et al.Psychopharmacology (Berl). 2013 Feb;225(3):637-46. doi: 10.1007/s00213-012-2851-5. Epub 2012 Sep 4.Psychopharmacology (Berl). 2013.PMID:22945514Free PMC article.
- Extended Detection Window for Gamma-Hydroxybutyrate in the Urine of an Elderly Woman.Berg JA, Rajendiran R, Serkland TT, Methlie CB, Hallin EI, Stokes CL.Berg JA, et al.J Anal Toxicol. 2023 Apr 14;47(4):e44-e47. doi: 10.1093/jat/bkad014.J Anal Toxicol. 2023.PMID:36847150Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical